相关实验视频
Updated: Jun 28, 2025

06:01
Transcranial Direct Current Stimulation for Online Gamers
Published on: November 9, 2019
8.0K
对比阿片类药物使用障碍患者在冲动性和注意力缺陷多动性障碍方面有问题的互联网使用和没有问题的患者
Neşe Burcu Bal1, Bahar Yeşil Örnek1
1Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Psychiatry Clinic, Ankara, Turkey.
概括
患有阿片类药物使用障碍 (OUD) 和问题性互联网使用 (PIU) 的个人表现出更高的ADHD症状和冲动性. 解决PIU和并发症对于有效的OUD治疗和管理ADHD症状至关重要.
科学领域:
- 精神病学是一个精神病学.
- 成 药物 药物 药物 药物
- 行为科学 行为科学
背景情况:
- 阿片类药物使用障碍 (OUD) 是一种复杂的疾病,通常与其他行为问题同时发生.
- 问题性互联网使用 (PIU) 越来越被认为是一种显著的并发症.
- 了解OUD,PIU和神经行为症状之间的相互作用对于综合护理至关重要.
研究的目的:
- 调查OUD和PIU患者注意力缺陷和多动性障碍 (ADHD) 症状和冲动性.
- 为了确定PIU在OUD患者中的患病率.
- 评估PIU和ADHD症状,冲动性,抑郁和焦虑之间的关系.
主要方法:
- 在一个成治疗中心对360名OUD患者进行了横截面研究.
- 参与者完成了经过验证的尺度:年轻人互联网成量表 (YIAS),贝克抑郁量表 (BDI),贝克焦虑量表 (BAI),巴拉特冲动性量表 (BIS) 和成人多动症自我报告量表 (ASRS).
- PIU被定义为50或更高的YIAS得分.
主要成果:
- 在OUD患者中观察到PIU的高并发症.
- 与非PIU组相比,PIU组的抑郁症 (BDI),焦虑症 (BAI) 和ADHD症状 (ASRS) 的得分显著更高 (p < 0.001).
- 增加的冲动性,包括运动,注意力和总BIS分数,与PIU有显著的关联 (p < 0.001).
结论:
- 在患有阿片类药物使用障碍的人群中,有问题的互联网使用非常普遍.
- 伴并发性PIU在OUD中与ADHD症状增加,冲动性,抑郁和焦虑有关.
- 对于OUD患者,建议采取综合治疗方法来解决PIU,ADHD症状和情绪健康问题.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
57
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
57
Drug Abuse and Addiction: Pharmacological Phenomena
469
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
469
Substance Use Disorders Affecting Sleep
166
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
166
Analgesia and Pain Management
614
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614
Opioid Receptors: Overview
764
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
764
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
188
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
188

